ARWR

ARROWHEAD PHARMACEUTICALS IN

CUSIP: 04280A100

Market Cap
-
Sector
Healthcare
Institutional Owners
0
Institutional Value
-

About

Arrowhead Pharmaceuticals is a clinical-stage biotechnology company focused on developing transformative medicines for the treatment of intractable diseases. The company utilizes its proprietary RNA interference (RNAi) platform to design drugs that target and silence disease-causing genes at the genetic level. Its pipeline primarily addresses therapeutic areas with high unmet medical needs, including cardiovascular, metabolic, hepatic, and pulmonary diseases.

Institutional Holders

Loading...